Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 23, 2025, titled "Dr. Reddy s announces its intention to appoint M/s. DeloitteHaskins & Sells LLP as Statutory Auditors effective from FY 2026-27".
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Reddy's Laboratories has announced its intention to appoint Deloitte Haskins & Sells LLP as its new Statutory Auditors for a five-year term starting from FY 2026-27 (ending March 31, 2027). This change is driven by the mandatory auditor rotation requirement under the Companies Act, 2013, as the current auditors S.R. Batliboi & Associates LLP complete their five-year tenure at the 42nd AGM in 2026. The Audit Committee has reviewed Deloitte's credentials and independence and indicated its intent to recommend the appointment, which the Board approved on July 23, 2025. Shareholder approval will be sought at the 2026 AGM.
This is a routine, regulator-mandated auditor rotation and not linked to any governance concerns. No immediate impact on shareholders or operations is expected; the appointment is subject to shareholder approval in 2026.